Key Laboratory for Forest Resources Conservation and Utilization in the Southwest Mountains of China, Ministry of Education, Southwest Forestry University, Kunming, 650224, PR China.
Key Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, PR China.
J Ethnopharmacol. 2021 Nov 15;280:114441. doi: 10.1016/j.jep.2021.114441. Epub 2021 Jul 22.
The genus Picrasma belongs to the Simaroubaceae family and contains six species which are mainly distributed in tropical and subtropical regions of Asia and America. The barks, roots, stems, branches, or leaves of several Picrasma species have been applied as folk medicines to treat fever, sore throat, dysentery, eczema, nausea, loss of appetite, diabetes mellitus, cancer, and hypertension.
A systematic summary on the botanic characterization, ethnopharmacological uses, phytochemistry, bioactivities and toxicity of species belonging to Picrasma was presented to facilitate the exploitation of the therapeutic potential of these plants.
The literatures about Picrasma were retrieved from a series of scientific search engines including Web of Science, SciFinder, PubMed, CNKI, Google Scholar, Elsevier, Wiley, ACS publications, and SpringerLink between 1970 and 2020. Plant names were validated by "The Plant List" (www.theplantlist.org).
As ethnopharmacological uses, Picrasma species are valuable folk medicines to treat fever, inflammation, dysentery, eczema, cancer, diabetics, skin infection, and so on. Up to now, a total of 361 compounds including 126 alkaloids, 132 quassinoids, 67 triterpenoids, and 36 miscellaneous compounds were reported from Picrasma species. Quassinoids and alkaloids are the principal constituents in the genus. The extracts and phytochemical constituents of Picrasma species demonstrate a wide range of bioactivities including cytotoxic, anti-inflammatory, antimicrobial, and other activities.
Picrasma species are widely used as traditional medicines, have diverse chemical constituents with obvious biological activities. Nevertheless, further studies are required on the Picrasma species to assert the ethnopharmacological uses, clarify their bioactive constituents, determine pharmacological actions, and toxicity. Therefore, the present review may provide a critical clue for future studies and further exploitations on Picrasma species.
Picrasma 属属于楝科,包含六个种,主要分布在亚洲和美洲的热带和亚热带地区。几种 Picrasma 物种的树皮、根、茎、枝或叶已被用作民间药物,用于治疗发热、喉炎、痢疾、湿疹、恶心、食欲不振、糖尿病、癌症和高血压。
对 Picrasma 属植物的植物学特征、民族药理学用途、植物化学、生物活性和毒性进行系统总结,以促进这些植物治疗潜力的开发。
从包括 Web of Science、SciFinder、PubMed、CNKI、Google Scholar、Elsevier、Wiley、ACS 出版物和 SpringerLink 在内的一系列科学搜索引擎中检索了有关 Picrasma 的文献,检索时间为 1970 年至 2020 年。植物名称通过"The Plant List"(www.theplantlist.org)进行验证。
作为民族药理学用途,Picrasma 种是治疗发热、炎症、痢疾、湿疹、癌症、糖尿病患者、皮肤感染等疾病的宝贵民间药物。到目前为止,从 Picrasma 种中总共报道了 361 种化合物,包括 126 种生物碱、132 种苦木素、67 种三萜和 36 种杂化合物。苦木素和生物碱是该属的主要成分。 Picrasma 种的提取物和植物化学成分表现出广泛的生物活性,包括细胞毒性、抗炎、抗菌和其他活性。
Picrasma 种广泛用作传统药物,具有多样化的化学成分和明显的生物活性。然而,需要对 Picrasma 种进行进一步研究,以证实其民族药理学用途、阐明其生物活性成分、确定药理作用和毒性。因此,本综述可为未来对 Picrasma 种的研究和进一步开发提供重要线索。